PRNewswire Bengaluru Karnataka [India] January 16 Bengaluru-based biotechnology startup CrisprBits Private Limited has ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Editas Medicine (EDIT – Research Report) yesterday and set a ...

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes ...

From fighting diseases to determining why you can't stand cilantro, genetics are the silent architects of your life. Here's ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...

To prepare students for the challenges and opportunities of an increasingly AI-driven world, Connecticut College has launched ...

Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it ...

(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

Three Iowa State researchers are being honored with the Presidential Early Career Award for Scientists and Engineers. The ...